JRI Rights Offering Results

Stanford ChemistInvesting Group LeaderFollow5ShareSavePlay(8min)CommentsSummaryNuveen Real Asset Income and Growth Fund completed an oversubscribed 1-for-4 rights offering at $12.40 per share, raising approximately $108.5 million.The rights offering led to a 31.25% increase in share count and a NAV/share hit of -2.38% for existing holders.JRI's premium triggered the offering, but post-announcement discount widening made the event dilutive, reinforcing tactical "sell and rebuy" strategies.With the offering over and JRI trading near historical discounts, the fund's 13.27% yield and normalized discount levels make it more attractive for forward allocations.CEF/ETF Income Laboratory members get exclusive access to our real-world portfolio. See all our investments here »gradyreese/E+ via Getty Images Nuveen Real Asset Income and Growth Fund's (JRI), a "real assets" themed closed-end fund, rights offering results are in. From the press release: Nuveen Real Asset Income and Growth Fund ((NYSE: JRI)) (the "Fund") today announced the This article was written byStanford Chemist20.71K FollowersFollowStanford Chemist is a scientific researcher by training. For the past decade he has been providing analysis and evidence-based ways of generating profitable investments with CEFs and ETFs. He leads the investing group CEF/ETF Income Laboratory. Features of the service include: managed income portfolios (targeting safe and reliable ~8% yields) making use of high-yield opportunities in the CEF and ETF fund space. These are geared toward both active and passive investors of all experience levels. The vast majority of {CEF/ETF Income Laboratory} holdings are also monthly-payers, for faster compounding and steady income streams. Other features include 24/7 chat, and trade alerts.Analyst’s Disclosure: I/we have a beneficial long position in the shares of UTF either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article. Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.